Researchers harness gene-editing to revolutionize how we grow food: 'We think that is a technology that can work'

As a result, the technology stands at a complicated intersection in the fight against a shifting climate. Breeding plants to ...
Life Sciences IP Review

Biotech sues AstraZeneca and Cellectis over mRNA patents

Complaint alleges the pair used Massachusetts company’s patented mRNA TALEN gene-editing technology without permission in ...
Seeking Alpha

Cellectis Provides Business Update and Reports Financial Results for Third Quarter and First Nine Months 2022

On October 11, at the European Society of Gene and Cell Therapy (ESGCT), Cellectis presented pre-clinical data that leverages TALEN® gene editing technology to develop a hematopoietic stem and ...

Cellectis to Present Data on Non-Viral Gene Therapy and TALE Base Editors at the ESGCT Annual Congress

Cellectis’ headquarters are in Paris, France, with locations in New York and Raleigh, NC. Cellectis is listed on the Nasdaq Global Market (ticker: CLLS) and on Euronext Growth (ticker: ALCLS). To find ...
Science Daily

MIT’s new precision gene editing tool could transform medicine

MIT scientists have found a way to make gene editing far safer and more accurate — a breakthrough that could reshape how we ...
WDAF-TV

Creative Biolabs Introduces Game-Changing CRISPR Solutions for Accelerated Gene Therapy Development

SHIRLEY, NY, UNITED STATES, May 22, 2025 /EINPresswire.com/ -- The gene therapy landscape has seen a paradigm shift in the last few years, mainly due to the advent of ...